advertisement
Joachim SC 9
Showing records 1 to 9 | Display all abstracts from Joachim SC79227 Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration
Reinhard J
Molecular Neurobiology 2019; 56: 4322-4345
78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Kuehn S; Meißner W
Frontiers in cellular neuroscience 2018; 12: 312
79227 Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration
Wiemann S
Molecular Neurobiology 2019; 56: 4322-4345
78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Grotegut P
Frontiers in cellular neuroscience 2018; 12: 312
79227 Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration
Joachim SC
Molecular Neurobiology 2019; 56: 4322-4345
78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Theiss C
Frontiers in cellular neuroscience 2018; 12: 312
79227 Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration
Palmhof M; Woestmann J
Molecular Neurobiology 2019; 56: 4322-4345
78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Dick HB; Joachim SC
Frontiers in cellular neuroscience 2018; 12: 312
79227 Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration
Denecke B; Wang Y; Downey GP; Faissner A
Molecular Neurobiology 2019; 56: 4322-4345
